COVID-19 Vaccinations

CURRENT UPDATE

12.00pm, Tuesday 29th December

Bondi Doctors is committed to providing patients with relevant and up-to-date information regarding the release of COVID-19 vaccines.

Currently, we are unable to confirm when the first vaccine will be available to our patients, however based on current information from the government, we anticipate we will have access to vaccines around March 2021.

We will continue to update our website regularly. We encourage you to register your interest to receive email updates about the administration of the vaccines.

Coming soon - Register your Interest to Receive a COVID-19 Vaccine

We want to ensure that any Bondi Doctors patient who wishes to receive the COVID-19 vaccine will be able to access the vaccine through us. In order to determine how many of our patients intend to receive the COVID 19 vaccine, we will soon be asking you to register your interest. 

By registering your interest you will assist us to secure enough vaccine stock to meet community demand. You will also be the first to know when we receive the vaccines, and when you can book an appointment to have the vaccine administered. 

COVID-19 Vaccinations Secured by Australia

The Australian Government has secured agreements for the supply of FOUR promising COVID-19 vaccines, provided they prove to be safe and effective. 

 

The University of Oxford / AstraZeneca vaccine

Australia has secured 53.8 million doses of this vaccine, with 3.8 million of these doses planned to be delivered in early 2021. Patients will likely require two doses based on early trial results. 

Should this vaccine be successful, Australia will be able to manufacture 50 million doses per month on behalf of AstraZeneca. 

 

Novavax vaccine

Australia has secured 51 million doses which will be made available throughout 2021. Patients will likely require two doses based on early trial results. 

 

Pfizer and BioNTech vaccine

Australia has secured 10 million doses, with the first supply expected to arrive in the first half of 2021. Patients will likely require two doses, about a month apart, based on early trial results.  

 

COVAX

It has not been confirmed how many doses of this vaccine have been secured by Australia through the World Health Organisation, however their commitment will allow the purchase of sufficient vaccine to cover 50% of the Australian population. This will initially be directed towards high-risk workers. 

 

Not all vaccines invested in by Australia are guaranteed to be successful. Each vaccine may have a safety and efficacy profile suited to different groups within the population. 

Proposed Rollout of COVID-19 Vaccines

When vaccines become available, supply will initially be limited and directed towards priority groups for vaccination. Whilst the details for this are not concrete, the rollout is likely to be separated into three groups:

 

GROUP 1:

Those who are at increased risk of exposure and hence being infected with and transmitting SARS-CoV-2 to others, or are in a setting with high transmission potential. 

This includes: health and aged care workers; other care workers, including disability support workers; and people in other settings where the risk of virus transmission is increased, which may include quarantine workers.

 

GROUP 2:

Those who have an increased risk, relative to others, of developing severe disease or outcomes from COVID-19.

This includes: Aboriginal and Torres Strait Islander people; people with underlying (chronic) select medical conditions; and the elderly (minimum age to be confirmed).

 

GROUP 3:

All remaining individuals that do not meet the above criteria of group 1 and 2.

Children will be the last to receive the vaccine.